Next Science

About:

Next Science pioneers innovative, proprietary technologies to address the problem of biofilm.

Website: https://www.nextscience.com/

Twitter/X: nextscience

Description:

Next Science provides commercialising and developing its Xbio technology, which is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria, in a range of products for the treatment of biofilm based infections.

Total Funding Amount:

$15.8M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Chatswood, New South Wales, Australia

Founded Date:

2012-01-01

Contact Email:

info(AT)nextscience.com

Founders:

Matthew Myntti

Number of Employees:

11-50

Last Funding Date:

2023-09-25

IPO Status:

Public

Industries:

© 2025 bioDAO.ai